| IGXT Stock | | | USD 0.17 0.00 0.00% |
Chairman
Dr. Horst G. Zerbe, Ph.D., is Chairman of the Board, President, Chief Executive Officer of IntelGenx Technologies Corporationration In addition, Dr. Zerbe has served as the President, Chief Executive Officer and Director of IntelGenx Corporationration, our Canadian Subsidiary, since 2005. Dr. Zerbe retired from his positions as President and Chief Executive Officer on January 1, 2014, and at the request of the Board was reappointed as President and CEO effective July 15, 2014. Dr. Zerbe has more than 35 years experience in the pharmaceutical industry. He started his career At Schwarz Pharma and subsequently at 3M Pharmaceuticals in Germany. From 1998 to 2005, he served as the president of Smartrix Technologies Inc. in Montreal prior thereto, from 1994 to 1998, he served as Vice President of RD and Technology Transfer at LTS Lohmann Therapy Systems in West Caldwell, NJ. During his assignments at 3M and LTS, he gained considerable experience in the technology transfer and commercial manufacturing of transdermal as well as oral film products. Dr. Zerbe has extensive executive level experience, and was responsible for many strategic and business initiatives. Dr. Zerbe was involved in new drug development and the acquisition and disposition of new drug candidates and other technology, licensing and distribution matters that are likely to affect our companys own business efforts. He has published numerous scientific papers in recognized journals and holds over 30 patents. Dr. Zerbe is married to Ingrid Zerbe, our Corporationrationrate Secretary. since 2014.
| Age | 76 |
| Tenure | 10 years |
| Phone | 514 331 7440 |
| Web | https://www.intelgenx.com |
Intelgenx Technologs Management Efficiency
The company has return on total asset
(ROA) of
(0.367) % which means that it has lost $0.367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(5.2896) %, meaning that it created substantial loss on money invested by shareholders. Intelgenx Technologs' management efficiency ratios could be used to measure how well Intelgenx Technologs manages its routine affairs as well as how well it operates its assets and liabilities.
Intelgenx Technologs currently holds 6.21
M in liabilities with Debt to Equity
(D/E) ratio of 6.42, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intelgenx Technologs has a current ratio of 3.55, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Debt can assist Intelgenx Technologs until it has trouble settling it off, either with new capital or with free cash flow. So, Intelgenx Technologs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intelgenx Technologs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intelgenx to invest in growth at high rates of return. When we think about Intelgenx Technologs' use of debt, we should always consider it together with cash and equity.
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange. Intelgenx Technologs [IGXT] is a
Pink Sheet which is traded through a dealer network over-the-counter (OTC).
Management Performance
Intelgenx Technologs Leadership Team
Elected by the shareholders, the Intelgenx Technologs' board of directors comprises two types of representatives: Intelgenx Technologs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelgenx. The board's role is to monitor Intelgenx Technologs' management team and ensure that shareholders' interests are well served. Intelgenx Technologs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelgenx Technologs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Intelgenx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Intelgenx Technologs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Intelgenx Pink Sheet Analysis
When running Intelgenx Technologs' price analysis, check to
measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to
predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.